Effects of a feed supplement, containing undenatured type II collagen (UC II®) and Boswellia Serrata, in the management of mild/moderate mobility disorders in dogs: A randomized, double-blind, placebo controlled, cross-over study
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0305697 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Marzia Stabile und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica (Di.Me.Pre-J), Università Degli Studi di Bari, Valenzano, Bari. Hauptthemen laut MEDLINE: Boswellia, Dietary Supplements, Collagen Type II, Cross-Over Studies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetoquinol,SA.
Themen: Mobilisation
Abstract (Originalsprache)
This study was designed as a randomized, placebo-controlled, double-blinded, cross-over trial performed to investigate the effects of a dietary supplement containing undenatured type II collagen (UCII ® ) and Boswellia Serrata on mobility, pain and joint metabolism in mild moderate osteoarthritis (OA) in dogs. A total of 60 dogs with mobility problems were evaluated and enrolled in the study. Seventeen of these dogs with mild/moderate OA were randomized to receive the product A (UCII ® + Boswellia Serrata supplement–UCII ® -BW) or product B (Placebo -PL), 1 chew per day for 8 weeks by oral route, and repeated in a crossover design after 4 weeks of washout period. All the subjects had veterinary evaluations during the trial and owners were requested to fill out a questionnaire on mobility impairment using the Liverpool Osteoarthritis in dogs scale (L.O.A.D.) at each time of the study. Objective tools were used to assess mobility, activity, and pain. Metabolomic analysis was performed on synovial fluid of most affected joint at the beginning and the end of the study. The results proved that UCII ® + Boswellia serrata supplemented group over a period of eight weeks results in an improvement of mobility impairment, already at 4 weeks of administration, according to the owner´s evaluation. In contrast, its absence increased the risk of OA crisis and decreased the pain threshold on the most affected joint. Furthermore, the synovial fluid metabolic profile showed moderate differences between the beginning and the end of the supplementation period, with a particular influence associated to the time of UCII ® -BW administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica (Di.Me.Pre-J), Università Degli Studi di Bari, Valenzano, Bari.
- Vetoquinol SA, Paris, France.
- Dipartimento di Scienze e Tecnologie Biologiche e Ambientali (DiSTeBA), Università del Salento, Lecce, Italia.
- Dipartimento di Economia e Finanza, Università degli Studi di Bari, Bari, Italia.
ORCID-Profile: Marzia Stabile, Crescenza Calculli, Angela Maria D'Uggento, Francesco Staffieri
Förderung
- Vetoquinol,SA
Zitieren
APA
Stabile, M., Fracassi, L., Lacitignola, L., Garcia-Pedraza, E., Girelli, C. R., Calculli, C., D'Uggento, A. M., Ribecco, N., Crovace, A., Fanizzi, F. P., & Staffieri, F. (2024). Effects of a feed supplement, containing undenatured type II collagen (UC II®) and Boswellia Serrata, in the management of mild/moderate mobility disorders in dogs: A randomized, double-blind, placebo controlled, cross-over study. PLOS ONE. https://doi.org/10.1371/journal.pone.0305697
Vancouver
Stabile M, Fracassi L, Lacitignola L, Garcia-Pedraza E, Girelli CR, Calculli C, et al. Effects of a feed supplement, containing undenatured type II collagen (UC II®) and Boswellia Serrata, in the management of mild/moderate mobility disorders in dogs: A randomized, double-blind, placebo controlled, cross-over study. PLOS ONE. 2024. doi:10.1371/journal.pone.0305697
BibTeX
@article{Stabile2024,
author = {Stabile, Marzia and Fracassi, Laura and Lacitignola, Luca and Garcia-Pedraza, Elena and Girelli, Chiara Roberta and Calculli, Crescenza and D'Uggento, Angela Maria and Ribecco, Nunziata and Crovace, Antonio and Fanizzi, Francesco Paolo and Staffieri, Francesco},
title = {Effects of a feed supplement, containing undenatured type II collagen (UC II®) and Boswellia Serrata, in the management of mild/moderate mobility disorders in dogs: A randomized, double-blind, placebo controlled, cross-over study},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0305697}
}
EUVIMED